Swedish inhalation research equipment company Inhalation Sciences (ISAB) announced that it has received notification that a US patent covering the aerosol generating technology in its PreciseInhale laboratory aerosol dosing system will soon be issued. In May 2019, ISAB announced that it intended to validate the PreciseInhale for clinical use.
The new patent is based on patent application 14/906,701. According to the company, the technology is already covered by patents in a number of European countries, including the UK, France, and Germany.
ISAB CEO Manoush Masarrat said, “This new patent is of vital strategic importance for us. Following our recently approved new patent for regional targeting, it is yet further proof of how we continue to be the leading innovators in aerosol and inhalation R&D, a fast-growing and ever more urgent market.”
Read the Inhalation Sciences press release.
